These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 20080)

  • 1. Effects of 5-(3,3-dimethyl-1-triazeno) imidazole-4-carboxamide [NSC 45388, DTIC] on neuroblastoma cells in culture.
    Culver B; Sahu SK; Vernadakis A; Prasad KN
    Biochem Biophys Res Commun; 1977 Jun; 76(3):778-83. PubMed ID: 20080
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of the antitumour agent 5-(3,3-dimethyl-1-triazeno imidazole-4-carboxamide (DTIC) on cyclic AMP levels in intact MH1C1 hepatoma cells.
    Haffner F; Christoffersen T
    Acta Pharmacol Toxicol (Copenh); 1980 Aug; 47(2):93-7. PubMed ID: 6254325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation of neuroblastoma cells in culture.
    Prasad KN
    Biol Rev Camb Philos Soc; 1975 May; 50(2):129-65. PubMed ID: 240451
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide and its metabolites on Novikoff hepatoma cells.
    Beal DD; Skibba JL; Whitnable KK; Bryan GT
    Cancer Res; 1976 Aug; 36(8):2827-31. PubMed ID: 179708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antitumour agent 5-(3,3-dimethyl-1-triazeno) imidazole-4-carboxamide (DTIC) inhibits rat liver cAMP phosphodiesterase and amplifies hormone effects in hepatocytes and hepatoma cells.
    Larsson PG; Haffner F; Brłnstad GO; Christoffersen T
    Br J Cancer; 1979 Nov; 40(5):768-73. PubMed ID: 228692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of 5-(3-methyl-1-triazeno)imidazole-4-carboxamide (NSC-407347), an alkylating agent derived from 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388).
    Mizuno NS; Decker RW; Zakis B
    Biochem Pharmacol; 1975 Mar; 24(5):615-9. PubMed ID: 1168474
    [No Abstract]   [Full Text] [Related]  

  • 7. Modulation in the levels and localization of plasminogen activator in differentiating neuroblastoma cells.
    Soreq H; Miskin R; Zutra A; Littauer UZ
    Brain Res; 1983 Apr; 283(2-3):257-69. PubMed ID: 6133597
    [No Abstract]   [Full Text] [Related]  

  • 8. Cyclic nucleotides in the regulation of expression of differentiated functions in neuroblastoma cells.
    Prasad KN; Sahu SK; Sinha PK
    J Natl Cancer Inst; 1976 Sep; 57(3):619-31. PubMed ID: 10449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclic-AMP-induced differentiation in neuroblastoma is independent of cell division rate.
    Waymire JC; Gilmer-Waymire K; Haycock JW
    Nature; 1978 Nov; 276(5684):194-5. PubMed ID: 33336
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term depression of two primary immune responses induced by a single dose of 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide (DTIC).
    Puccetti P; Giampietri A; Fioretti MC
    Experientia; 1978 Jun; 34(6):799-800. PubMed ID: 658308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and antileukemic activities of furanyl, pyranyl, and ribosyl derivatives of 4-(3,3-dimethyl-1-triazeno)imidazole-5-carboxamide and 3-(3,3-dimethyl-1-triazeno)pyrazole-4-carboxamide.
    Earl RA; Townsend LB
    J Med Chem; 1979 Nov; 22(11):1422-5. PubMed ID: 533891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Depression of the immune response to lymphoma allotransplant with the use of 5-(3,3-dimethyl-1-triazeno)-imidazol-4-carboxamide (DTIC)].
    Giampietri A; Puccetti P; Circolo A; Menconi E
    Boll Soc Ital Biol Sper; 1977 Jun; 53(11):922-6. PubMed ID: 597414
    [No Abstract]   [Full Text] [Related]  

  • 13. Nerve growth factor (NGF) induced differentiation of human neuroblastoma cells.
    Pavelić K; Spaventi S
    Int J Biochem; 1987; 19(12):1237-40. PubMed ID: 2830153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carcinogenicity of the antineoplastic agent, 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide, and its metabolites in rats.
    Beal DD; Skibba JL; Croft WA; Cohen SM; Bryan GT
    J Natl Cancer Inst; 1975 Apr; 54(4):951-7. PubMed ID: 1127724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of sodium butyrate on mammalian cells in culture: a review.
    Prasad KN; Sinha PK
    In Vitro; 1976 Feb; 12(2):125-32. PubMed ID: 2548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the mechanism of action of DTIC (NSC-45388).
    Bono VH
    Cancer Treat Rep; 1976 Feb; 60(2):141-8. PubMed ID: 944096
    [No Abstract]   [Full Text] [Related]  

  • 17. The immunodepressive and hematotoxic activity of imidazole-4-carboxamide,5-(3,3-dimethyl-1-triazeno) in mice.
    Vecchi A; Fioretti MC; Mantovani A; Barzi A; Spreafico F
    Transplantation; 1976 Dec; 22(6):619-24. PubMed ID: 795112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human neuroblastoma cell culture: effect of 5-bromodeoxyuridine on morphological differentiation and levels of neural enzymes.
    Prasad KN; Mandal B; Kumar S
    Proc Soc Exp Biol Med; 1973 Oct; 144(1):38-42. PubMed ID: 4149193
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of interferon-gamma and its interaction with retinoic acid on human neuroblastoma differentiation.
    Wuarin L; Verity MA; Sidell N
    Int J Cancer; 1991 Apr; 48(1):136-41. PubMed ID: 1673449
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.